Literature DB >> 29181872

Validation of T1w-based segmentations of white matter hyperintensity volumes in large-scale datasets of aging.

Mahsa Dadar1, Josefina Maranzano2, Simon Ducharme2, Owen T Carmichael3, Charles Decarli4, D Louis Collins1.   

Abstract

INTRODUCTION: Fluid-attenuated Inversion Recovery (FLAIR) and dual T2w and proton density (PD) magnetic resonance images (MRIs) are considered to be the optimum sequences for detecting white matter hyperintensities (WMHs) in aging and Alzheimer's disease populations. However, many existing large multisite studies forgo their acquisition in favor of other MRI sequences due to economic and time constraints.
METHODS: In this article, we have investigated whether FLAIR and T2w/PD sequences are necessary to detect WMHs in Alzheimer's and aging studies, compared to using only T1w images. Using a previously validated automated tool based on a Random Forests classifier, WMHs were segmented for the baseline visits of subjects from ADC, ADNI1, and ADNI2/GO studies with and without T2w/PD and FLAIR information. The obtained WMH loads (WMHLs) in different lobes were then correlated with manually segmented WMHLs, each other, age, cognitive, and clinical measures to assess the strength of the correlations with and without using T2w/PD and FLAIR information.
RESULTS: The WMHLs obtained from T1w-Only segmentations correlated with the manual WMHLs (ADNI1: r = .743, p < .001, ADNI2/GO: r = .904, p < .001), segmentations obtained from T1w + T2w + PD for ADNI1 (r = .888, p < .001) and T1w + FLAIR for ADNI2/GO (r = .969, p < .001), age (ADNI1: r = .391, p < .001, ADNI2/GO: r = .466, p < .001), and ADAS13 (ADNI1: r = .227, p < .001, ADNI2/GO: r = .190, p < 0.001), and NPI (ADNI1: r = .290, p < .001, ADNI2/GO: r = 0.144, p < .001), controlling for age.
CONCLUSION: Our results suggest that while T2w/PD and FLAIR provide more accurate estimates of the true WMHLs, T1w-Only segmentations can still provide estimates that hold strong correlations with the actual WMHLs, age, and performance on various cognitive/clinical scales, giving added value to datasets where T2w/PD or FLAIR are not available.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Azheimer's disease; T1w hypointensities; cerebrovascular disease; cognitive impairment; small vessel disease; white matter integrity

Mesh:

Year:  2017        PMID: 29181872      PMCID: PMC6866430          DOI: 10.1002/hbm.23894

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  40 in total

1.  Pathologic findings of silent hyperintense white matter lesions on MRI.

Authors:  M Takao; A Koto; N Tanahashi; Y Fukuuchi; M Takagi; S Morinaga
Journal:  J Neurol Sci       Date:  1999-08-15       Impact factor: 3.181

2.  Adaptive non-local means denoising of MR images with spatially varying noise levels.

Authors:  José V Manjón; Pierrick Coupé; Luis Martí-Bonmatí; D Louis Collins; Montserrat Robles
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

3.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis.

Authors:  Paul Schmidt; Christian Gaser; Milan Arsic; Dorothea Buck; Annette Förschler; Achim Berthele; Muna Hoshi; Rüdiger Ilg; Volker J Schmid; Claus Zimmer; Bernhard Hemmer; Mark Mühlau
Journal:  Neuroimage       Date:  2011-11-18       Impact factor: 6.556

Review 4.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

5.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

Review 6.  Lesion location and cognitive impact of cerebral small vessel disease.

Authors:  J Matthijs Biesbroek; Nick A Weaver; Geert Jan Biessels
Journal:  Clin Sci (Lond)       Date:  2017-04-25       Impact factor: 6.124

7.  White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Authors:  Frank A Provenzano; Jordan Muraskin; Giuseppe Tosto; Atul Narkhede; Ben T Wasserman; Erica Y Griffith; Vanessa A Guzman; Irene B Meier; Molly E Zimmerman; Adam M Brickman
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

8.  Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.

Authors:  J Maranzano; D A Rudko; D L Arnold; S Narayanan
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

9.  Periventricular cerebral white matter lesions predict rate of cognitive decline.

Authors:  Jan Cees De Groot; Frank-Erik De Leeuw; Matthijs Oudkerk; Jan Van Gijn; Albert Hofman; Jellemer Jolles; Monique M B Breteler
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

10.  Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.

Authors:  Adam M Brickman; Frank A Provenzano; Jordan Muraskin; Jennifer J Manly; Sonja Blum; Zoltan Apa; Yaakov Stern; Truman R Brown; José A Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2012-12
View more
  21 in total

1.  Associations between cerebral blood flow and structural and functional brain imaging measures in individuals with neuropsychologically defined mild cognitive impairment.

Authors:  Chan-Mi Kim; Rachel L Alvarado; Kimberly Stephens; Hsiao-Ying Wey; Dany J J Wang; Elizabeth C Leritz; David H Salat
Journal:  Neurobiol Aging       Date:  2019-11-06       Impact factor: 4.673

2.  HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.

Authors:  Ryan Sanford; Jeremy Strain; Mahsa Dadar; Josefina Maranzano; Alexandre Bonnet; Nancy E Mayo; Susan C Scott; Lesley K Fellows; Beau M Ances; D Louis Collins
Journal:  AIDS       Date:  2019-06-01       Impact factor: 4.177

3.  Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.

Authors:  Xi Chen; Kaitlin E Cassady; Jenna N Adams; Theresa M Harrison; Suzanne L Baker; William J Jagust
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

4.  Validation of T1w-based segmentations of white matter hyperintensity volumes in large-scale datasets of aging.

Authors:  Mahsa Dadar; Josefina Maranzano; Simon Ducharme; Owen T Carmichael; Charles Decarli; D Louis Collins
Journal:  Hum Brain Mapp       Date:  2017-11-27       Impact factor: 5.038

5.  The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.

Authors:  Cassandra J Anor; Mahsa Dadar; D Louis Collins; M Carmela Tartaglia
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-04-02

6.  Show Me Your White Matter, I Will Tell You Who You Are ….

Authors:  Gregory Kuchcinski; Clinton B Wright
Journal:  Stroke       Date:  2021-01-07       Impact factor: 7.914

7.  Beware of white matter hyperintensities causing systematic errors in FreeSurfer gray matter segmentations!

Authors:  Mahsa Dadar; Olivier Potvin; Richard Camicioli; Simon Duchesne
Journal:  Hum Brain Mapp       Date:  2021-03-30       Impact factor: 5.038

8.  Heterogeneity of Cerebral White Matter Lesions and Clinical Correlates in Older Adults.

Authors:  Keun-Hwa Jung; Kimberly A Stephens; Kathryn M Yochim; Joost M Riphagen; Chan Mi Kim; Randy L Buckner; David H Salat
Journal:  Stroke       Date:  2021-01-07       Impact factor: 10.170

9.  White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease.

Authors:  Mahsa Dadar; Seyed-Mohammad Fereshtehnejad; Yashar Zeighami; Alain Dagher; Ronald B Postuma; D Louis Collins
Journal:  Mov Disord Clin Pract       Date:  2020-07-18

10.  White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.

Authors:  Mahsa Dadar; Yashar Zeighami; Yvonne Yau; Seyed-Mohammad Fereshtehnejad; Josefina Maranzano; Ronald B Postuma; Alain Dagher; D Louis Collins
Journal:  Neuroimage Clin       Date:  2018-09-27       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.